Purpose-built for physicians Combined GLP-1/amylin analog bests monotherapy for HbA1c drop, weight loss in diabetes Key takeaways: Combination cagrilintide and semaglutide conferred a 15.6% weight loss at 32 weeks in type 2 diabetes
PO329 Use of the Virtual Tool Lina Chatbot for Guidance on Insulin Administration in Diabetic Patients Attended at the Endocrinology Outpatient Clinic Guimares ML1
Read more: What Is the Cost of Rybelsus with Medicare?
Superior Clinical Results Phase 2 data showed up to 24.2% body weight reduction at 48 weeks surpassing both semaglutide and tirzepatide
With this approval, and by launching a generic for Saxenda, we will provide patients in the US the first ever generic GLP-1 product specifically indicated for weight loss, said Ernie Richardsen, senior vice president, Head of US Commercial Generics at Teva
Our customers have demonstrated a clear gap in supply and demand, so were making it easy for everyone to share their experience and be a part of advocating for better access to the medications they need, said Andrew Dudum, CEO and co-founder of Hims & Hers